No.	Topic
1	Blood Brain Barrier From Physiology To Therapeutics 血脑屏障-从生理学到治疗学
2	Blood-Brain Barrier Mechanisms of Neurodegeneration in Alzheimer’s Disease 阿尔茨海默病神经退化的血脑屏障机制
3	Perivascular drainage of Amyloid-Beta and the pathogenesis of Alzheimer's disease 血管周围淀粉样蛋白（Aβ） 的排泄和阿尔茨海默病的发病机制
4	Vascular Contributions To Cognitive Impairment 血管性认知障碍
5	Frontotemporal Dementia: A Quarter Century Of Progress 额颞叶痴呆：近25年的进展
6	Modifiable risk factors for dementia: world Alzheimer Report 2014 可变的痴呆危险因素：全球阿尔茨海默病报告（2014）
7	Is There a Need For Larger Prevention Trials? 有必要进行更大规模的预防研究吗？
8	Experiential And Psychosocial Risk Factors For Dementia 痴呆的实验和社会心理学危险因素
9	Is It Time to Go Beyond Randomized Controlled Trials? 是时间超越随机对照试验了吗？
10	Clinician staging of Mild Cognitive Impairment （MCI) severity yields neuropsychological, neuroimaging, genetic susceptibility, and cerebrospinal fluid differences among subtypes: the Vanderbilt Memory And Aging Project 轻度认知障碍（MCI)严重度的临床分期与神经心理学，神经影像学，遗传易感性，以及不同亚型脑脊液差别的一致性：Vanderbilt记忆与衰老项目
11	Microinfarcts: Key To Prevention Of The Vascular Burden In Dementia? 微梗塞：预防痴呆血管负荷的关键？
12	CSF Biomarkers Vs PET Biomarkers CSF生物标记物 VS. PET生物标记物
13	AlzBiomarker Database On Established And Novel CSF And Plasma Biomarkers For Alzheimer’s Disease AlzBiomarker数据库：已证实的和新型的阿尔茨海默病相关的CSF和血浆生物标记物
14	Clinical And Research Utility Of Alzheimer Biomarkers 阿尔茨海默病生物标记物在临床和研究中的作用
15	Open Challenges: Real Time Data, Novel Ways To Understand Dementia 公开挑战：实时数据，认识痴呆的新途径